Harris KW - Search Results

1

Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro.

Tuomela JM, Sandholm JA, Kaakinen M, Hayden KL, Haapasaari KM, Jukkola-Vuorinen A, Kauppila JH, Lehenkari PP, Harris KW, Graves DE, Selander KS. Tuomela JM, et al. Among authors: harris kw. Breast Cancer Res Treat. 2016 Jan;155(2):261-71. doi: 10.1007/s10549-016-3683-5. Epub 2016 Jan 18. Breast Cancer Res Treat. 2016. PMID: 26780557

2

Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition.

Merrell M, Suarez-Cuervo C, Harris KW, Väänänen HK, Selander KS. Merrell M, et al. Among authors: harris kw. Breast Cancer Res Treat. 2003 Oct;81(3):231-41. doi: 10.1023/a:1026126430905. Breast Cancer Res Treat. 2003. PMID: 14620918

3

Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.

Ilvesaro JM, Merrell MA, Li L, Wakchoure S, Graves D, Brooks S, Rahko E, Jukkola-Vuorinen A, Vuopala KS, Harris KW, Selander KS. Ilvesaro JM, et al. Among authors: harris kw. Mol Cancer Res. 2008 Oct;6(10):1534-43. doi: 10.1158/1541-7786.MCR-07-2005. Mol Cancer Res. 2008. PMID: 18922969

4

Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer.

Jukkola-Vuorinen A, Rahko E, Vuopala KS, Desmond R, Lehenkari PP, Harris KW, Selander KS. Jukkola-Vuorinen A, et al. Among authors: harris kw. J Innate Immun. 2009;1(1):59-68. doi: 10.1159/000151602. Epub 2008 Aug 28. J Innate Immun. 2009. PMID: 20375566 Free PMC article.

5

Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells.

Sandholm J, Kauppila JH, Pressey C, Tuomela J, Jukkola-Vuorinen A, Vaarala M, Johnson MR, Harris KW, Selander KS. Sandholm J, et al. Among authors: harris kw. Breast Cancer Res Treat. 2012 Apr;132(2):411-9. doi: 10.1007/s10549-011-1590-3. Epub 2011 May 24. Breast Cancer Res Treat. 2012. PMID: 21607583

6

Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.

Tuomela J, Sandholm J, Karihtala P, Ilvesaro J, Vuopala KS, Kauppila JH, Kauppila S, Chen D, Pressey C, Härkönen P, Harris KW, Graves D, Auvinen PK, Soini Y, Jukkola-Vuorinen A, Selander KS. Tuomela J, et al. Among authors: harris kw. Breast Cancer Res Treat. 2012 Sep;135(2):481-93. doi: 10.1007/s10549-012-2181-7. Epub 2012 Jul 31. Breast Cancer Res Treat. 2012. PMID: 22847512

7

DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells.

Tuomela J, Sandholm J, Kaakinen M, Patel A, Kauppila JH, Ilvesaro J, Chen D, Harris KW, Graves D, Selander KS. Tuomela J, et al. Among authors: harris kw. Breast Cancer Res Treat. 2013 Dec;142(3):477-87. doi: 10.1007/s10549-013-2762-0. Epub 2013 Nov 10. Breast Cancer Res Treat. 2013. PMID: 24212717 Free PMC article.

8

Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.

Sandholm J, Lehtimäki J, Ishizu T, Velu SE, Clark J, Härkönen P, Jukkola-Vuorinen A, Schrey A, Harris KW, Tuomela JM, Selander KS. Sandholm J, et al. Among authors: harris kw. Oncotarget. 2016 Dec 27;7(52):87373-87389. doi: 10.18632/oncotarget.13570. Oncotarget. 2016. PMID: 27888633 Free PMC article.

9

Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.

Chandler MR, Keene KS, Tuomela JM, Forero-Torres A, Desmond R, Vuopala KS, Harris KW, Merner ND, Selander KS. Chandler MR, et al. Among authors: harris kw. PLoS One. 2017 Sep 8;12(9):e0183832. doi: 10.1371/journal.pone.0183832. eCollection 2017. PLoS One. 2017. PMID: 28886076 Free PMC article.

10

Tumor necrosis factor-alpha induces interleukin-6 production via extracellular-regulated kinase 1 activation in breast cancer cells.

Suarez-Cuervo C, Harris KW, Kallman L, Väänänen HK, Selander KS. Suarez-Cuervo C, et al. Among authors: harris kw. Breast Cancer Res Treat. 2003 Jul;80(1):71-8. doi: 10.1023/a:1024443303436. Breast Cancer Res Treat. 2003. PMID: 12889600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page